In vivo generated hematopoietic stem cells from genome edited induced pluripotent stem cells are functional in platelet-targeted gene therapy of murine hemophilia A. Haematologica 2020 Apr;105(4):e175-e179
Date
07/13/2019Pubmed ID
31296582Pubmed Central ID
PMC7109733DOI
10.3324/haematol.2019.219089Scopus ID
2-s2.0-85083225461 (requires institutional sign-in at Scopus site) 9 CitationsAuthor List
Wang D, Zhang G, Gu J, Shao X, Dai Y, Li J, Pan X, Yao S, Xu A, Jin Y, Huang J, Shi Q, Zhu J, Xi X, Chen Z, Chen SAuthor
Qizhen Shi MD, PhD Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsBlood Platelets
Cell Differentiation
Genetic Therapy
Hematopoietic Stem Cells
Hemophilia A
Induced Pluripotent Stem Cells
Mice